Q1 2018

Filed May 15, 2018 · 10-Q · 45 days after period end · 0001493152-18-007134

Q1 2018 · 10-Q

Revenue—

Net Income

-$3.78M

N/M vs Q1 2017

EPS Diluted

-$0.12

N/M vs Q1 2017

Operating Income-$3,906,000N/M

Operating Cash Flow-$2,753,000N/M

Same quarter

Metric	Q1 2018	Q1 2017	Q1 2016	Q1 2015
Revenue	—	—	$0.00	—
Net Income	-$3.78M	-$4.70M	-$2.93M	-$1.37M
EPS Diluted	-$0.12	-$0.16	-$0.12	-$0.08

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Insight Molecular Diagnostics Inc. · CIK 1642380 · Engraved from SEC EDGAR